Occupational Safety and Effort-Reward Imbalance in Pharmaceutical Manufacturing Firms
Occupational Safety and Effort-Reward Imbalance in Pharmaceutical Manufacturing Firms

Summary/Abstract: The pharmaceutical manufacturing industry in Nigeria plays a pivotal role in supplying essential healthcare products to a burgeoning population. However, this industry is characterized by unique challenges related to occupational safety and effort-reward imbalance (ERI) that significantly impact the well-being of employees. Despite the critical importance of these issues, there is a dearth of comprehensive research focusing on the intersection of occupational safety and ERI within this specific sector in Nigeria. Thus, the study aimed at investigating the influence of occupational safety on effort-reward imbalance among employees of pharmaceutical manufacturing companies in Nigeria. Three null hypotheses were formulated. 715 employees were conveniently sampled from 42 selected pharmaceutical manufacturing firms in Southeastern Nigeria for descriptive survey study. Findings revealed that occupational safety and health has no significant influence on effort-reward imbalance among employees of pharmaceutical manufacturing firms in Southeastern, Nigeria { R2 = .002, F= 1.19, β= -.028, t= -1.09, p> .05}; health insurance policies have no significant impact on the physical wellbeing of factory employees in pharmaceutical manufacturing companies, in Southeast, Nigeria{X2 = 53.51, F = 52.41, p> 0.05} and that safety policies and procedures do not have any significant influence on physical work load of factory employees in pharmaceutical manufacturing companies, in Southeast, Nigeria {R2= -.001, F = 0.55, β= .02, t= 0.74, p> .05}. The study then recommended that pharmaceutical manufacturing companies should endeavor to employ experienced HSE officers, who are ingrained with the principles and techniques of occupational safety and health; and that the National Labour Congress through their executives should prepare a bill that will make it mandatory that all factory employees should be indemnified by health insurance policies upon resumption of duties in pharmaceutical manufacturing firms.

• Details
• Contents